HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Candidemia — Clinical Guidelines

Overview

Candidemia refers to the presence of Candida species in the bloodstream, often leading to systemic infection with potential complications including ocular involvement such as candidemia-related endophthalmitis 1 2.

Diagnosis

Blood cultures are essential for diagnosing candidemia 6.

Ocular screening via indirect funduscopy may be considered, though routine screening is debated 1 3 4.

Prevalence of ocular candidiasis (OC) is approximately 10.7%, with Candida endophthalmitis (CE) occurring in about 3.1% of patients screened 2.

Higher rates of CE are noted in Asian populations compared to European and American studies 2.

Management

First-line antifungal treatment typically includes echinocandins (e.g., caspofungin) or liposomal amphotericin B for severe cases 6.

Fluconazole may be used for less severe cases, particularly if the causative organism is susceptible 6.

Treatment decisions should primarily be based on systemic infection management rather than ocular findings alone 4.

Early initiation of appropriate antifungal therapy is crucial for reducing mortality 6.

Special Populations

Elderly: Advanced age (≥65 years) is a risk factor for higher mortality 6.

Comorbidities: Patients with higher Sequential Organ Failure Assessment (SOFA) scores and prior antibiotic use have increased mortality risk 6.

Pediatrics and Pregnancy: Specific data on these populations is not provided in the abstracts.

Key Recommendations

Routine ocular screening for all patients with candidemia is not universally recommended due to low rates of endophthalmitis and minimal impact on management 1 4 (Evidence: Moderate).

Treatment of candidemia should focus on systemic antifungal therapy rather than ocular findings, guided by the causative Candida species and patient-specific factors 4 6 (Evidence: Strong).

Further research is needed to identify high-risk features that may justify selective ophthalmologic examination in candidemia patients 1 3 (Evidence: Expert opinion).

References

1 Mishra AV, Loh GK, Ehmann DS. Inpatient ophthalmology consultations for candidemia: a literature review and opinion. Current opinion in ophthalmology 2025. link 2 Phongkhun K, Pothikamjorn T, Srisurapanont K, Manothummetha K, Sanguankeo A, Thongkam A et al.. Prevalence of Ocular Candidiasis and Candida Endophthalmitis in Patients With Candidemia: A Systematic Review and Meta-Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023. link 3 O'Donnell M, Eller AW, Waxman EL, Clancy CJ, Nguyen MH. Screening for Ocular Candidiasis Among Patients With Candidemia: Is It Time to Change Practice?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022. link 4 Breazzano MP, Bond JB, Bearelly S, Kim DH, Donahue SP, Lum F et al.. American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis. Ophthalmology 2022. link 5 Schalk R, Mai T, Ochmann T. [Peripheral intravenous lines : A multifaceted topic]. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2020. link 6 Kato H, Yoshimura Y, Suido Y, Shimizu H, Ide K, Sugiyama Y et al.. Mortality and risk factor analysis for Candida blood stream infection: A multicenter study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019. link 7 Tientadakul P, Chuntarut A. Establishing an external quality assessment scheme for point-of-care international normalized ratio in Thailand. International journal of laboratory hematology 2015. link 8 Schultz V, Colombo AL, Pasqualotto AC. Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians. Revista da Sociedade Brasileira de Medicina Tropical 2013. link 9 Ylipalosaari P, Ala-Kokko TI, Karhu J, Koskela M, Laurila J, Ohtonen P et al.. Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment. Critical care (London, England) 2012. link

Candidemia